Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Erasca, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 132 | 1 | 146 | +15 |
| Shares | 232.0M | 24.3K | 230.9M | −1.15M (−0.5%) |
| Value | $633.4M | $66.3K | $579.5M | −$53.9M (−8.5%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (27)
Institutions that held Erasca, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (12)
Institutions that held Erasca, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Fred Alger Management, LLC | 230,854 | $630.2K |
| Verition Fund Management LLC | 169,460 | $462.6K |
| EntryPoint Capital, LLC | 75,647 | $206.5K |
| Point72 Asset Management, L.P. | 63,599 | $173.6K |
| Gsa Capital Partners LLP | 60,848 | $166.0K |
| Tudor Investment Corp Et Al | 47,830 | $130.6K |
| Valence8 US LP | 46,923 | $128.1K |
| Brown Wealth Management, LLC | 30,000 | $81.9K |
| Virtu Financial LLC | 15,685 | $43.0K |
| Bayesian Capital Management, LP | 13,200 | $36.0K |
| Capital Performance Advisors LLP | 332 | $906 |
| US Bancorp | 84 | $229 |
Not filed for Q4 2024 yet (1)
Institutions that held Erasca, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Edmonds Duncan Registered Investment Advisors, LLC | 24,280 | $66.3K |